By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



3334 East Coast Hwy 157

Corona del Mar  California  92625  U.S.A.
Phone: 949-721-4063 Fax: 949-760-1030



Company News
ProSensa Holding N.V. (RNA) And CureDuchenne Strengthen Long-Term Collaboration With An Additional [Eur]5M To Advance DMD Pipeline 8/11/2014 4:28:22 PM
CureDuchenne Media Statement Regarding ProSensa Holding N.V. (RNA) Announcement Of Regulatory Path Forward For Drisapersen As A Potential Treatment For DMD 6/3/2014 10:01:49 AM
CureDuchenne Release: “CureDuchenne Ventures” Launched to Accelerate Drug Discovery and Development for Duchenne Muscular Dystrophy 9/26/2013 9:58:01 AM
CureDuchenne to Host Drug Development and Clinical Trial Participation – A Webinar for the Rare Disease Community on September 13 9/10/2013 6:48:51 AM
Statement From CureDuchenne Regarding ProSensa B.V. IPO 6/28/2013 9:31:59 AM
CureDuchenne Partners With French Researchers to Expand eDystrophin Database 3/29/2013 9:23:49 AM
CureDuchenne Release: 2nd Annual Knoxville Brewfest to Raise Funds to Find a Cure for Duchenne Muscular Dystrophy 6/11/2012 3:40:11 PM
CureDuchenne Announces Third Annual Scientific Summit and Worlwide Webcast 1/25/2012 8:48:50 AM
CureDuchenne Appoints Michael Kelly as Chief Scientific Officer 12/14/2011 7:05:02 AM
CureDuchenne Announces Latest Events in the 2011 Cure Duchenne Adventures Series 9/15/2010 12:50:51 PM